Analyst Ratings For NYSE:ZYME – Zymeworks (NYSE:ZYME)
Today, Ladenburg Thalmann initiated coverage on NYSE:ZYME – Zymeworks (NYSE:ZYME) with a Buy with a price target of $25.00.
Some recent analyst ratings include
- 5/14/2018-Ladenburg Thalmann initiated coverage with a Buy rating.
- 5/11/2018-Barclays Upgrade from a “Underweight ➝ Equal Weight” rating to a “” rating.
- 3/19/2018-Raymond James initiated coverage with a Outperform ➝ Outperform rating.
- 9/30/2017-Cormark Reiterated Rating of Buy.
- 5/23/2017-Citigroup initiated coverage with a Buy ➝ Buy rating.
- 5/23/2017-Wells Fargo initiated coverage with a Outperform ➝ Outperform rating.
- 5/23/2017-Canaccord Genuity initiated coverage with a Buy ➝ Buy rating.
Recent Trading Activity for NYSE:ZYME – Zymeworks (NYSE:ZYME)
Shares of NYSE:ZYME – Zymeworks closed the previous trading session at 16.38 up +0.55 3.47% with 15.59000015258789 shares trading hands.